key: cord-0772851-lws18jkv
authors: Deana, Cristian
title: Immunonutrition in perioperative care of covid-19 patients: an old weapon for a new disease?
date: 2021-02-17
journal: Braz J Anesthesiol
DOI: 10.1016/j.bjane.2020.12.018
sha: 172889bfe33e3622d8a6708954b704ef2120814a
doc_id: 772851
cord_uid: lws18jkv

nan

through the breakdown of proteins, lipolysis, and an increase in oxidative stress. These factors may also impair the patient's potential to recover from surgery or chronic critical illness, increasing the COVID-19 mortality rate. [2] During the pandemic, a proportion of COVID-19 patients have had to undergo scheduled or urgent surgery, and evidence has demonstrated these patients to be more inflamed and procoagulant. As a consequence, mortality risk is increased since they present a higher risk of developing thrombotic and postoperative respiratory complications compared with COVID-19 negative patients. In some cases, postoperative respiratory complications have resulted in symptoms of acute respiratory failure very similar to those of acute respiratory distress syndrome (ARDS), thus requiring prolonged mechanical ventilation and ICU stay. [3] An intriguing, but as yet unanswered, question regards whether immunonutrition could constitute an adjunctive tool in the perioperative care of COVID-19 patients. In COVID-19 patients, given their enhanced state of inflammation, ω-3 polyunsaturated fatty acids probably represent the most important component of immunonutrition: these nutrients have been demonstrated to reduce the secretion of proinflammatory cytokines by macrophages, modulate neutrophil function, and stabilize cytokines and reactive oxygen species. [5] For this reason, we suggest that immunonutrition be started as soon as possible in cases of COVID-19 because, in addition to being malnourished, these patients present a severe negative nitrogen balance and a deregulated immune system. Although immunonutrition is usually started preoperatively in scheduled surgery, during the ongoing COVID-19 pandemic, most surgical interventions have been urgent procedures, making it difficult to initiate immunonutrition adequately in advance of surgery (an ideal time frame would be seven days).

Whenever possible, immunonutrition should be administered through the enteric route, favouring per os if the patient is able to swallow, or via the nasogastric route if not. There are few contraindications to the enteric route (namely, bowel obstruction, bowel ischemia, and gastrointestinal bleeding): in such cases, the parenteral route must be considered as early as possible.

In summary, considering that no adverse outcomes of immunonutrition have been reported in either the surgical or postoperative ICU setting, this adjunctive tool should not be discarded a priori, but instead considered and immediately applied in the perioperative care of COVID-19 patients. 

Emerging coronaviruses: Genome structure, replication, and pathogenesis

Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations

Factors Associated With Surgical Mortality and Complications Among Patients With and Without Coronavirus Disease 2019 (COVID-19) in Italy

Immunonutrition vs Standard Nutrition for Cancer Patients: A Systematic Review and Meta-Analysis (Part 1)

Preoperative frailty assessment combined with prehabilitation and nutrition strategies: Emerging concepts and clinical outcomes

The author declares no conflicts of interest.